As of 1:32 PM on the 18th, SK is trading at 309,500 KRW, down 2.67% from the previous day. The trading volume is 678,534 shares, which is 45.66% of the previous day's volume. SK is known as the holding company of the SK Group.

On June 15, Choi Jung-wook, a researcher at Hana Financial Investment, stated, "While there may be concerns that the listing of SK Biopharm could dampen sentiment toward SK due to high expectations for SK Biopharm, considering the learning effect after the listing of Samsung Biologics, the current SK Biopharm listing is expected to serve as a significant opportunity for supply and demand improvement for SK. It is anticipated that investment sentiment toward SK will continue to improve until SK’s stock price rises to a certain appropriate value level after the SK Biopharm listing." He set SK’s target price at 320,000 KRW.

Over the past five days, individual investors have net purchased 570,417 shares of SK, while foreign investors and institutions have net sold 327,287 shares and 229,556 shares, respectively.

※Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an automated article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.




This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing